Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products